IBB vs. CANC ETF Comparison

Comparison of iShares Nasdaq Biotechnology Index Fund (IBB) to Tema Oncology ETF (CANC)
IBB

iShares Nasdaq Biotechnology Index Fund

IBB Description

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$147.10

Average Daily Volume

1,324,453

Number of Holdings *

185

* may have additional holdings in another (foreign) market
CANC

Tema Oncology ETF

CANC Description Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$28.94

Average Daily Volume

23,542

Number of Holdings *

8

* may have additional holdings in another (foreign) market
Performance
Period IBB CANC
30 Days 8.15% 8.23%
60 Days 9.87% 8.19%
90 Days 10.63% 4.97%
12 Months 15.75%
6 Overlapping Holdings
Symbol Grade Weight in IBB Weight in CANC Overlap
AMGN B 1.0% 3.39% 1.0%
BPMC C 1.0% 3.32% 1.0%
EXEL A 1.0% 3.21% 1.0%
INCY C 1.0% 3.16% 1.0%
NTLA D 1.0% 3.41% 1.0%
REGN A 1.0% 5.97% 1.0%
IBB Overweight 179 Positions Relative to CANC
Symbol Grade Weight
RPHM F 1.0%
OVID F 1.0%
MRNS D 1.0%
AMLX D 1.0%
RAPT F 1.0%
ACRS D 1.0%
VTYX F 1.0%
BMEA F 1.0%
ALXO F 1.0%
CHRS F 1.0%
ATAI D 1.0%
LYEL F 1.0%
CRBU D 1.0%
THRD D 1.0%
PGEN C 1.0%
NAUT D 1.0%
BLUE D 1.0%
MGTX C 1.0%
MLYS C 1.0%
TRML D 1.0%
ZNTL F 1.0%
PRME F 1.0%
AVIR C 1.0%
CABA F 1.0%
MGNX F 1.0%
SVRA B 1.0%
TSHA F 1.0%
VNDA C 1.0%
PHAT C 1.0%
TERN C 1.0%
RVNC D 1.0%
QURE C 1.0%
ALLO D 1.0%
SLRN D 1.0%
KALV C 1.0%
VYGR C 1.0%
VERV D 1.0%
MXCT C 1.0%
TBPH C 1.0%
EDIT D 1.0%
REPL C 1.0%
YMAB D 1.0%
FLGT C 1.0%
OPK C 1.0%
SPRY C 1.0%
ALEC D 1.0%
ITOS B 1.0%
FULC B 1.0%
ORIC C 1.0%
DNA F 1.0%
TNGX C 1.0%
QTRX D 1.0%
AVXL B 1.0%
ERAS C 1.0%
URGN C 1.0%
SAGE F 1.0%
PACB D 1.0%
ABUS B 1.0%
NUVB B 1.0%
ARCT F 1.0%
SRRK D 1.0%
CSTL C 1.0%
WVE C 1.0%
RGNX D 1.0%
ADPT B 1.0%
ZYME C 1.0%
ELVN C 1.0%
SANA F 1.0%
TVTX C 1.0%
IRON D 1.0%
COGT B 1.0%
AUPH C 1.0%
HUMA B 1.0%
TARS F 1.0%
PLRX C 1.0%
FDMT F 1.0%
RCUS D 1.0%
OLMA B 1.0%
CTKB D 1.0%
CGEM D 1.0%
ETNB C 1.0%
ANAB C 1.0%
CDNA B 1.0%
ARQT C 1.0%
SMMT B 1.0%
VIR D 1.0%
DAWN C 1.0%
RLAY D 1.0%
KNSA B 1.0%
MRVI B 1.0%
PRTA D 1.0%
IRWD D 1.0%
EWTX C 1.0%
NRIX C 1.0%
XNCR F 1.0%
RXRX F 1.0%
GPCR F 1.0%
KURA D 1.0%
KROS C 1.0%
JANX D 1.0%
VERA C 1.0%
BCRX C 1.0%
DVAX F 1.0%
MNKD C 1.0%
MIRM C 1.0%
AKRO C 1.0%
ARVN D 1.0%
NVAX D 1.0%
IMVT C 1.0%
VCYT C 1.0%
SNDX C 1.0%
APGE C 1.0%
LGND B 1.0%
IOVA D 1.0%
TXG F 1.0%
RCKT D 1.0%
PTGX C 1.0%
MORF B 1.0%
NVCR B 1.0%
GERN B 1.0%
KYMR B 1.0%
FTRE C 1.0%
MYGN B 1.0%
SWTX F 1.0%
BEAM C 1.0%
PTCT D 1.0%
VCEL C 1.0%
ACLX C 1.0%
AGIO C 1.0%
NUVL C 1.0%
RYTM C 1.0%
MRUS D 1.0%
ADMA C 1.0%
DYN C 1.0%
DNLI C 1.0%
IDYA B 1.0%
FOLD C 1.0%
BHVN D 1.0%
ACAD C 1.0%
TWST C 1.0%
XENE B 1.0%
AXSM B 1.0%
ARWR D 1.0%
RARE C 1.0%
BBIO F 1.0%
RNA C 1.0%
CRNX B 1.0%
APLS F 1.0%
CRSP F 1.0%
ALKS B 1.0%
KRYS C 1.0%
MDGL C 1.0%
ROIV D 1.0%
RVMD B 1.0%
CYTK D 1.0%
BRKR D 1.0%
IONS B 1.0%
HALO B 1.0%
ITCI B 1.0%
PCVX C 1.0%
RGEN B 1.0%
MEDP D 1.0%
INSM B 1.0%
NTRA D 1.0%
CRL B 1.0%
SRPT C 1.0%
TECH B 1.0%
NBIX A 1.0%
UTHR B 1.0%
BMRN C 1.0%
WAT B 1.0%
ILMN B 1.0%
ALNY A 1.0%
BIIB F 1.0%
MTD A 1.0%
MRNA F 1.0%
IQV B 1.0%
VRTX A 1.0%
GILD B 1.0%
IBB Underweight 2 Positions Relative to CANC
Symbol Grade Weight
MRK F -4.65%
ARGX A -3.56%
Compare ETFs